Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robbert G van der Most

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|October 31, 2022
Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?Sofia M Buonocore, Robbert G van der Most
The New England Journal of Medicine|June 9, 2006
A better way for a cancer cell to dieRichard A Lake, Robbert G van der Most
Human Vaccines & Immunotherapeutics|September 22, 2017
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccinePhilippe Moris, Erik Jongert, Robbert G van der Most
International Immunology|December 28, 2002
Prolonged presence of effector-memory CD8 T cells in the central nervous system after dengue virus encephalitisRobbert G van der Most, Kaja Murali-Krishna, Rafi Ahmed
Discovery Medicine|August 14, 2010
Combining immunotherapy with chemotherapy to treat cancerRobbert G van der Most, Bruce W S Robinson, Richard A Lake
Current Opinion in Immunology|June 25, 2008
Immunogenic anti-cancer chemotherapy as an emerging conceptNicole M Haynes, Robbert G van der Most, Richard A Lake, et al.
Cancer Research|January 21, 2006
Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunityRobbert G van der Most, Andrew Currie, Bruce W S Robinson, et al.
Virology|May 31, 2002
Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in miceRobbert G van der Most, Laurie E Harrington, Vicki Giuggio, et al.
Journal of Virology|February 13, 2009
Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infectionJoseph N Blattman, E John Wherry, Sang-Jun Ha, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2012
Peripheral CD8(+) T cell proliferation is prognostic for patients with advanced thoracic malignanciesMelanie J McCoy, Anna K Nowak, Robbert G van der Most, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|October 31, 2022
Narcolepsy and H1N1 influenza immunology a decade later: What have we learned?Sofia M Buonocore, Robbert G van der Most
The New England Journal of Medicine|June 9, 2006
A better way for a cancer cell to dieRichard A Lake, Robbert G van der Most
Human Vaccines & Immunotherapeutics|September 22, 2017
Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccinePhilippe Moris, Erik Jongert, Robbert G van der Most
International Immunology|December 28, 2002
Prolonged presence of effector-memory CD8 T cells in the central nervous system after dengue virus encephalitisRobbert G van der Most, Kaja Murali-Krishna, Rafi Ahmed
Discovery Medicine|August 14, 2010
Combining immunotherapy with chemotherapy to treat cancerRobbert G van der Most, Bruce W S Robinson, Richard A Lake
Current Opinion in Immunology|June 25, 2008
Immunogenic anti-cancer chemotherapy as an emerging conceptNicole M Haynes, Robbert G van der Most, Richard A Lake, et al.
Cancer Research|January 21, 2006
Cranking the immunologic engine with chemotherapy: using context to drive tumor antigen cross-presentation towards useful antitumor immunityRobbert G van der Most, Andrew Currie, Bruce W S Robinson, et al.
Virology|May 31, 2002
Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in miceRobbert G van der Most, Laurie E Harrington, Vicki Giuggio, et al.
Journal of Virology|February 13, 2009
Impact of epitope escape on PD-1 expression and CD8 T-cell exhaustion during chronic infectionJoseph N Blattman, E John Wherry, Sang-Jun Ha, et al.
Cancer Immunology, Immunotherapy : CII|October 17, 2012
Peripheral CD8(+) T cell proliferation is prognostic for patients with advanced thoracic malignanciesMelanie J McCoy, Anna K Nowak, Robbert G van der Most, et al.
Pageof 4